Haven't posted on this message board, or any for that matter, for quite some time now.

I'm surprised that POZN is trading in the $5's. Unlike most rest of the stock market, which is up over 50% since hitting their March lows, POZN is trending down towards those lows.

I would think with Trex. royalties going from 5% to 18% in just two months, and possible Vimovo approval coming 4 months later, and initiation of PA325 phase 3 trials sometime this quarter, that POZN's value should be north of this level.

Am I missing something?